Track BioLight Life Sciences's receivables ($670K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
BioLight Life Sciences (BOLT.TA) currently reports a receivables of $670K as of June 2026. That compares with $870K in the prior-year period — down 22.9% year over year. Use the charts on this page to explore BioLight Life Sciences's receivables history and peer comparisons.
BioLight Life Sciences's receivables decreased from $870K to $670K — a 22.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
BioLight Life Sciences reported $670K in receivables as of June 2026. That compares with $870K in the prior-year period — down 22.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $670K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioLight Life Sciences, and consider following BOLT.TA for alerts when major investors trade the stock.